Search

Your search keyword '"STENOTROPHOMONAS maltophilia"' showing total 1,154 results

Search Constraints

Start Over You searched for: Descriptor "STENOTROPHOMONAS maltophilia" Remove constraint Descriptor: "STENOTROPHOMONAS maltophilia" Database Academic Search Index Remove constraint Database: Academic Search Index
1,154 results on '"STENOTROPHOMONAS maltophilia"'

Search Results

1. Evaluation of clinical outcomes and risk factors associated with mortality in patients with Stenotrophomonas maltophilia bloodstream infection: a multicenter study.

2. Cefiderocol susceptibility of 146 Stenotrophomonas maltophilia strains clinically isolated from blood in two Japanese hospitals over a 10-year period.

3. Colonisation by multidrug-resistant organisms in health workers in primary care: narrow spectrum oral antimicrobials are a risk factor.

4. Discovery of a new class of bacterial heme-containing C[dbnd]C cleaving oxygenases.

5. Navigating the Current Treatment Landscape of Metallo-β-Lactamase-Producing Gram-Negative Infections: What are the Limitations?

6. Efficacy of two different microbial consortia on salinity tolerance in chickpea: an in-planta evaluation on biochemical, histochemical, and genomic aspects.

7. Protein-protein interaction network study of metallo-beta-lactamase-L1 present in Stenotrophomonas maltophilia and identification of potential drug targets.

8. A pan-genomic analysis based multi-epitope vaccine development by targeting Stenotrophomonas maltophilia using reverse vaccinology method: an in-silico approach.

9. From Glory to Decline: Uncovering Causes of Oak Decline in Iran.

10. Analysis of Stenotrophomonas maltophilia infections in lower respiratory tract samples at a university hospital: 5 year data.

11. Substrate preference, RNA binding and active site versatility of Stenotrophomonas maltophilia nuclease SmNuc1, explained by a structural study.

12. Antibiotic Resistance and Virulence Factors in Clinical Isolates of Stenotrophomonas maltophilia from Hospitalized Patients in Tehran, Iran.

13. Microbial richness and air chemistry in aerosols above the PBL confirm 2,000-km long-distance transport of potential human pathogens.

14. Stenotrophomonas maltophilia uses a c-di-GMP module to sense the mammalian body temperature during infection.

15. Drug Resistance in Biofilm and Planktonic Cells of Achromobacter spp., Burkholderia spp., and Stenotrophomonas maltophilia Clinical Isolates.

16. Selenium Bandages and Cotton Cloth That Kill Microorganisms in Wounds.

17. Anti-Stenotrophomonas maltophilia Mechanism of Rose Essential Oil: A Metabolomic Study.

18. Acquired resistance of Stenotrophomonas maltophilia to antimicrobials induced by herbicide paraquat dichloride.

19. The Engineered Lysin CF-370 Is Active Against Antibiotic-Resistant Gram-Negative Pathogens In Vitro and Synergizes With Meropenem in Experimental Pseudomonas aeruginosa Pneumonia.

20. Evaluation of BACTECTM FX and BacT/AlertTM Automated Blood Culture Systems for Detection of Clinically Relevant Bacterial and Yeast Species.

21. Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in Japan.

22. Screening and identification of functional bacterial attachment genes in aerobic granular sludge.

23. Stenotrophomonas maltophilia‐associated odontogenic cerebral abscess in an immunocompetent patient: A case report.

24. Elexacaftor/tezacaftor/ivacaftor's effects on cystic fibrosis infections are maintained, but not increased, after 3.5 years of treatment.

25. Temporal analysis of prevalence and antibiotic-resistance patterns in Stenotrophomonas maltophilia clinical isolates in a 19-year retrospective study.

26. Gram-negative bacterial infections in surgical intensive care unit patients following abdominal surgery: high mortality associated with Stenotrophomonas maltophilia infection.

27. Presence of intracellular bacterial communities in uroepithelial cells, a potential reservoir in symptomatic and non-symptomatic people.

28. Disinfection of sink drains to reduce a source of three opportunistic pathogens, during Serratia marcescens clusters in a neonatal intensive care unit.

29. UNRAVELING THE POTENTIAL OF LIQUID ENDOPHYTIC BACTERIAL INOCULANTS FOR ENHANCING FORAGE SORGHUM GROWTH UNDER SIMULATED SALINE STRESS CONDITIONS: AN IN-VITRO EVALUATION.

30. Biocontrol potential of native Algerian bacteria isolated from greenhouses against Botrytis cinerea and Oidium neolycopersici on tomato.

31. Stenotrophomonas maltophilia skin infection in an immunocompetent patient: Primary cutaneous CD30+ T‐cell lymphoproliferative disorder or pseudolymphoma?

32. Assessment of the prognosis, frequency, and isolated bacteria in ventilator-associated pneumonia among patients with severe coronavirus disease 2019 pneumonia: A single-center retrospective observational study.

33. Presumptive Stenotrophomonas maltophilia– Associated Multisystemic Granulomatous Disease in Aquatic Turtles.

34. Hemorrhagic Pneumonia in a Kidney Transplant Recipient Caused by Stenotrophomonas Maltophilia Infection: A Case Report.

35. An evaluation of a Stenotrophomonas maltophilia outbreak due to commercial arterial blood gas collection kit.

36. Production of highly cytotoxic and low immunogenic L-asparaginase from Stenotrophomonas maltophilia EMCC2297.

37. Risk factors for mortality in Stenotrophomonas maltophilia bacteremia – a meta-analysis.

38. Diversity and antibiotic resistance in bacteria associated with symptoms of bacterial infection in Costa Rican crops.

39. The Importance of Nonpharmacological Applications in the Management of Infections Caused by Stenotrophomonas maltophilia in Pediatric Patients: A Single-Center Experience.

40. Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population.

41. In the eye of the ophthalmologist: the corneal microbiome in microbial keratitis.

42. Prevalence and antimicrobial resistance profiles of mastitis causing bacteria isolated from dairy goats in Mukurweini Sub‐County, Nyeri County, Kenya.

43. In vitro activity of ceftazidime/avibactam, cefiderocol, meropenem/vaborbactam and imipenem/relebactam against clinical strains of the Stenotrophomonas maltophilia complex.

44. Clinical Outcomes of Trimethoprim/Sulfamethoxazole in Critically Ill Patients with Stenotrophomonas maltophilia Bacteremia and Pneumonia Utilizing Renal Replacement Therapies.

45. Optimization of fermentation conditions of fig leaves and its effect on content of active ingredients.

46. Detection of multidrug-resistant organisms of concern including Stenotrophomonas maltophilia and Burkholderia cepacia at a referral hospital in Kenya.

47. Human genetic associations of the airway microbiome in chronic obstructive pulmonary disease.

48. Morphogenetic characterization of Stenotrophomonas maltophilia infecting white stripe disease of rice (Oryza sativa L.).

49. Development of CuO Nanoparticles from the Mucus of Garden Snail Cornu aspersum as New Antimicrobial Agents.

50. Antibacterial and antibiofilm activities of diclofenac against levofloxacin-resistant Stenotrophomonas maltophilia isolates; emphasizing repurposing of diclofenac.

Catalog

Books, media, physical & digital resources